IMPACT Therapeutics Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series C1
  • Latest Deal Amount
  • $50M
Latest Deal Amount
  • Investors
  • 13

IMPACT Therapeutics General Information

Description

Developer of novel therapeutics intended to treat cancer and other life-threatening diseases. The company is dedicated towards the discovery and development process of targeted anti-cancer therapeutics based on synthetic lethality.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 12F, New Bund Times Square
  • 399 Haiyang West Road, Pudong District
  • Shanghai, Shanghai 200126
  • China
+86 021 0000 0000

IMPACT Therapeutics Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IMPACT Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series C1) 27-Jul-2020 $50M 0000 00000 Completed Generating Revenue
3. Later Stage VC (Series C) 03-Aug-2018 0000 0000 00000 Completed Clinical Trials - General
2. Later Stage VC (Series B) 22-Feb-2016 $10M $16M Completed Clinical Trials - General
1. Later Stage VC (Series A) 14-Jan-2015 $6M $6M Completed Clinical Trials - General
To view IMPACT Therapeutics’s complete valuation and funding history, request access »

IMPACT Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of novel therapeutics intended to treat cancer and other life-threatening diseases. The company is dedicated t
Drug Discovery
Shanghai, China
0000
0000 0000-00-00
00000000000 0000

000000

adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
0000 000000000
Lebanon, NH
000 As of 0000
00000
000000 - 000 00000

00000000

tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitat
0000 000000000
Saint Louis, MO
0 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IMPACT Therapeutics Competitors (40)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adimab Venture Capital-Backed Lebanon, NH 000 00000 000000 - 000 00000
000000000000000 Venture Capital-Backed Saint Louis, MO 0 000.00 00000000000 000.00
00000000 Venture Capital-Backed New York, NY 0 000 0000000000 0 000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
00000000 0000000 Private Equity-Backed Beijing, China 00 00000 0000000 0000 00000
You’re viewing 5 of 40 competitors. Get the full list »

IMPACT Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Jun Bao Ph.D Chief Executive Officer & President
Suixiong Cai Ph.D Executive Vice President & Chief Technology Officer
You’re viewing 2 of 3 executive team members. Get the full list »

IMPACT Therapeutics Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ausun Pharma Corporation Minority 000 0000 000000 0
Shenzhen Capital Group Venture Capital Minority 000 0000 000000 0
TopAlliance Corporation Minority 000 0000 000000 0
Decheng Capital Venture Capital Minority 000 0000 000000 0
China Orient Summit Capital Real Estate Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

IMPACT Therapeutics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 00 000 20-Aug-2020 00000 0000000 Drug Discovery 000 000 00.0
To view IMPACT Therapeutics’s complete investments history, request access »